CD‐MOF Based pH/ROS Sensitive 5‐ASA Delivery System for Ulcerative Colitis Therapy
Advanced Healthcare Materials · 2025-08 · 14 (22)
DOI: 10.1002/adhm.202501160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 23.06.2025. Verfasst von Yanxue Si und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Materials Utilization of Nonmetallic Minerals and Solid Wastes, National Laboratory of Mineral Materials, School of Materia…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Mesalamine, Metal-Organic Frameworks, Reactive Oxygen Species. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Guangdong Provincial Key Laboratory of Advanced Biomaterials.
Abstract (Originalsprache)
5‐Aminosalicylic acid (5‐ASA) is the first‐line drug for ulcerative colitis (UC), which encounters therapeutic constraints due to the poor water solubility and absorption by the upper gastrointestinal. Here, a cyclodextrin‐based metal‐organic framework (CD‐MOF) is used as a carrier for 5‐ASA (ASA@CM) to enhance its solubility. To improve the targeted release 5‐ASA, ASA@CM is incorporated into sodium alginate/ L ‐arginine complex (SA‐LA) to obtain the desired microspheres (ASA@CM/SL) by electrospray. ASA@CM/SL safeguards 5‐ASA against the harsh gastrointestinal environment and provides favorable delivery to the colon. The anti‐inflammatory and anti‐oxidant activity is studied by measuring inflammatory factors and reactive oxygen species (ROS). The therapeutic effect of ASA@CM/SL on UC mice induced with dextran sulfate sodium is assessed. The biosafety by evaluating cytotoxicity and organ toxicity is studied. ASA@CM/SL shows excellent therapeutic effects for UC, as evidenced by its alleviation of inflammatory response and restoration of disrupted intestinal barriers. ASA@CM/SL features low cytotoxicity and low organ toxicity. This study provides a potential strategy for improving 5‐ASA solubility and delivery efficiency, which may also be applied to broadly tackle various small hydrophobic molecules to treat UC and other intestinal diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Materials Utilization of Nonmetallic Minerals and Solid Wastes, National Laboratory of Mineral Materials, School of Materials Science and Technology, China University of Geosciences (Beijing),…
- Laboratory of Theoretical and Computational Nanoscience, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, P. R. China.
- NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, National Institutes for Food and Drug Control, 2 Tiantan Xi Li, Beijing, 100050, P. R. China.
- School of Environmental and Chemical Engineering, Foshan University, Foshan, 528000, P. R. China.
- Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guang…
ORCID-Profile: Xingyu Jiang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Guangdong Provincial Key Laboratory of Advanced Biomaterials
- Guangdong Innovative and Entrepreneurial Research Team Program
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Science and Technology Program
- Guangdong Major Talent Introduction Project
- National Key Research and Development Program of China
Zitieren
APA
Si, Y., Cha, R., Zhang, P., Zhou, F., Yuan, W., & Jiang, X. (2025). CD‐MOF Based pH/ROS Sensitive 5‐ASA Delivery System for Ulcerative Colitis Therapy. Advanced Healthcare Materials, 14(22). https://doi.org/10.1002/adhm.202501160
Vancouver
Si Y, Cha R, Zhang P, Zhou F, Yuan W, Jiang X. CD‐MOF Based pH/ROS Sensitive 5‐ASA Delivery System for Ulcerative Colitis Therapy. Advanced Healthcare Materials. 2025;14(22). doi:10.1002/adhm.202501160
BibTeX
@article{Si2025,
author = {Si, Yanxue and Cha, Ruitao and Zhang, Pai and Zhou, Fengshan and Yuan, Wenbing and Jiang, Xingyu},
title = {CD‐MOF Based pH/ROS Sensitive 5‐ASA Delivery System for Ulcerative Colitis Therapy},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {22},
doi = {10.1002/adhm.202501160}
}
EUVIMED